DTW — DTE ENERGY CO

NYSE · Utilities · Electric Utilities · CIK 936340 ·
Last close
$20.08
Market Cap
$3.60B
52W High
$22.10
52W Low
$20.04
ADV30
33,791
Next earnings
Lyra Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development and commercialization of anti-inflammatory therapies for the treatment of patients with chronic rhinosinusitis. Its technology is designed to deliver medicines directly to the affected tissue for sustained periods with a single administration. The company's product candidates include LYR-210, an anti-inflammatory implantable drug matrix which is in Phase III clinical trial for the treatment of chronic rhinosinusitis (CRS); and LYR-220 for CRS patients who have failed previous medical management and continue to require treatment to manage CRS symptoms. It has a collaboration agreement with LianBio Inflammatory Limited to develop and commercialize LYR-210 in mainland China, Hong Kong, Taiwan, Macau, South Korea, Singapore, and Thailand. The company was formerly known as 480 Biomedical, Inc. and changed its name to Lyra Therapeutics, Inc. in July 2018. Lyra Therapeutics, Inc. was incorporated in 2005 and is headquartered in Watertown, Massachusetts.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Dec 2024 8,718,000,000 3,013,000,000 517,000,000 477,000,000 48,846,000,000 24,000,000 37,142,000,000
Dec 2023 8,664,000,000 2,987,000,000 538,000,000 332,000,000 44,755,000,000 26,000,000 33,700,000,000
Dec 2022 15,753,000,000 5,534,000,000 545,000,000 387,000,000 42,683,000,000 33,000,000 32,282,000,000
Dec 2021 11,145,000,000 4,355,000,000 405,000,000 25,000,000 39,719,000,000 28,000,000 31,006,000,000

Annual Trend (SEC EDGAR, last 10y)

Revenues vs Net Income (last 10y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Dec 2024 38,235,000,000 2,243,000,000 1,397,000,000 48,846,000,000 37,142,000,000
Dec 2023 57,684,000,000 1,748,000,000 1,083,000,000 44,755,000,000 33,700,000,000
Dec 2022 44,892,000,000 1,495,000,000 907,000,000 42,683,000,000 32,282,000,000
Dec 2021 34,269,000,000 1,555,000,000 1,368,000,000 39,719,000,000 31,006,000,000
Dec 2020 5,704,000,000 445,000,000 340,000,000 45,496,000,000 32,907,000,000
Dec 2019 7,028,000,000 542,000,000 401,000,000 42,268,000,000 30,432,000,000
Dec 2018 7,506,000,000 504,000,000 361,000,000 36,288,000,000 25,571,000,000
Dec 2017 6,472,000,000 585,000,000 400,000,000 33,767,000,000 11,592,000,000
Dec 2016 2,566,000,000 381,000,000 247,000,000 32,041,000,000 11,273,000,000
Dec 2015 2,984,000,000 461,000,000 273,000,000 28,662,000,000 11,107,000,000

TTM Snapshot

Revenues TTM
$44,280,000,000
NetIncome TTM
$1,221,000,000
OpCashFlow TTM
$0
Assets (Latest)
$48,846,000,000
Forward EPS

Peers — same industry

TickerNameMarket CapLastDaily %
KEN Kenon Holdings Ltd. $3.61B $69.37
OTTR Otter Tail Corp $3.88B $92.34
CWEN Clearway Energy, Inc. $3.89B $32.09
CIG ENERGY CO OF MINAS GERAIS $4.06B $2.13
CIG-C ENERGY CO OF MINAS GERAIS $3.09B $3.23

Recent Insider Activity

No insider activity indexed for this ticker.